Xencor PE ratio XNCR

Share price divided by earnings per share over the last twelve months, since 2016.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 70.5×; Feb 2023
10-year median: 55.1×
10-year range: 11.6× to 112×
Peer median: 14.1×

Xencor has no meaningful PE ratio today: it lost $2.17 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Feb 2023, at 70.5×.

On the days it had one over the last ten years, its median was 55.1×, from 11.6× in Jun 2022 to 112× in Nov 2021.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2023	70.5×	57.4×	78.6×
2022	55.4×	11.6×	92.3×
2021	112×	84.4×	112×
2020	62.4×	56.6×	72.2×
2019	58.9×	41.2×	68.7×
2018	n/m a value too high to mean anything
2017	54.3×	22.6×	58.0×
2016	27.4×	20.2×	28.6×

Against its peers

Companies in Drug Manufacturers - General nearest Xencor's size, closest first, today.

Company	PE ratio
XNCRXencor	n/m
ANIPANI Pharmaceuticals	15.4×
HRMYHarmony Biosciences	11.7×
PAHCPhibro Animal Health	15.9×
PBHPrestige Consumer Healthcare	13.4×
ANABAnaptysbio	10.7×
PCRXPacira BioSciences	104×
NRIXNurix Therapeutics	11.0×
OMEROmeros	10.9×
AMPHAmphastar Pharmaceuticals	14.8×
OGNOrganon	17.9×
Peer median	14.1×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Xencor

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.